Olivier Pohl

Title: Olivier Pohl: Innovator in Oral Formulations for Preterm Labor Management

Introduction

Olivier Pohl is a notable inventor based in Switzerland, recognized for his contributions to the field of pharmaceutical formulations. His work primarily focuses on developing oral formulations that address critical medical needs, particularly in the management of preterm labor and premature birth.

Latest Patents

Olivier Pohl holds a patent for "Oral Formulations Of Pyrrolidine Derivatives." This invention addresses the need for a convenient oral formulation that provides a fast onset of action and good bioavailability of a compound acting as an OT-R antagonist. The patent describes a dispersible tablet that includes a specific compound and various pharmaceutically acceptable excipients. This formulation is intended for the treatment and prevention of several disorders, including preterm labor, premature birth, and other related conditions.

Career Highlights

Olivier Pohl has made significant strides in his career, particularly through his work at Obseva S.A. His innovative approach to pharmaceutical formulations has positioned him as a key player in the industry. Despite having no patents attributed to him, his research and development efforts have contributed to advancements in medical treatments.

Collaborations

Olivier Pohl collaborates with various professionals in the field, including his coworker Andre Chollet. Their combined expertise enhances the development of effective pharmaceutical solutions.

Conclusion

Olivier Pohl's work in oral formulations represents a significant advancement in the management of preterm labor and related disorders. His innovative contributions continue to impact the pharmaceutical industry positively.